These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9748425)

  • 1. Identification of oxidized low-density lipoprotein in human serum by NMR spectroscopy.
    Jankowski J; Nofer JR; Tepel M; Griewel B; Schlüter H; Assmann G; Zidek W
    Clin Sci (Lond); 1998 Oct; 95(4):489-95. PubMed ID: 9748425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of plasma very low density lipoprotein, low density lipoprotein and high density lipoprotein on platelet aggregation in endogenous hypertriglyceridemia].
    Deng Z; Liu B; Zhou J; Zhang Z; Liu Y; Bai H
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Oct; 34(4):704-7. PubMed ID: 14619587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study on serum oxidized low density lipoprotein and anti-oxidized competence in patient with coronary heart disease].
    Li GX; Li P
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Sep; 35(5):690-2. PubMed ID: 15460421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationships between serum levels of autoantibodies against oxidized low density lipoproteins, lipid-soluble antioxidants and apolipoprotein B in patients with coronary heart disease.
    Bakalova RA; Hadzhimitova V; Ribarov S
    Gen Physiol Biophys; 2000 Mar; 19(1):103-13. PubMed ID: 10930142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies to oxidized low density lipoprotein: the relationship to low density lipoprotein fatty acid composition in diabetes.
    Griffin ME; McInerney D; Fraser A; Johnson AH; Collins PB; Owens D; Tomkin GH
    Diabet Med; 1997 Sep; 14(9):741-7. PubMed ID: 9300223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial.
    Otvos JD; Collins D; Freedman DS; Shalaurova I; Schaefer EJ; McNamara JR; Bloomfield HE; Robins SJ
    Circulation; 2006 Mar; 113(12):1556-63. PubMed ID: 16534013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gemfibrozil reduces small low-density lipoprotein more in normolipemic subjects classified as low-density lipoprotein pattern B compared with pattern A.
    Superko HR; Berneis KK; Williams PT; Rizzo M; Wood PD
    Am J Cardiol; 2005 Nov; 96(9):1266-72. PubMed ID: 16253595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility of plasma low density lipoprotein to cupric ion-induced peroxidation in patients with variant angina.
    Miwa K; Miyagi Y; Fujita M
    J Am Coll Cardiol; 1995 Sep; 26(3):632-8. PubMed ID: 7642852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship of TFPI, Lp(a), and oxidized LDL antibody levels in patients with coronary artery disease.
    Bilgen D; Sönmez H; Ekmekçi H; Ulutin T; Oztürk Z; Kökoğlu E; Bayram C; Soner A; Domaniç N
    Clin Biochem; 2005 Jan; 38(1):92-6. PubMed ID: 15607324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma very-low-density lipoprotein, low-density lipoprotein, and high-density lipoprotein oxidative modification induces procoagulant profiles in endogenous hypertriglyceridemia.
    Bai H; Liu BW; Deng ZY; Shen T; Fang DZ; Zhao YH; Liu Y
    Free Radic Biol Med; 2006 May; 40(10):1796-803. PubMed ID: 16678017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of marine n-3 fatty acid supplementation on lipoprotein subclasses measured by nuclear magnetic resonance in subjects with type II diabetes.
    Mostad IL; Bjerve KS; Lydersen S; Grill V
    Eur J Clin Nutr; 2008 Mar; 62(3):419-29. PubMed ID: 17327864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endurance exercise training raises high-density lipoprotein cholesterol and lowers small low-density lipoprotein and very low-density lipoprotein independent of body fat phenotypes in older men and women.
    Halverstadt A; Phares DA; Wilund KR; Goldberg AP; Hagberg JM
    Metabolism; 2007 Apr; 56(4):444-50. PubMed ID: 17378998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased oxidizability of plasma low density lipoprotein from patients with coronary artery disease.
    Chiu HC; Jeng JR; Shieh SM
    Biochim Biophys Acta; 1994 Jan; 1225(2):200-8. PubMed ID: 8280789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HDL oxidability and its protective effect against LDL oxidation in Type 2 diabetic patients.
    Sanguinetti SM; Brites FD; Fasulo V; Verona J; Elbert A; Wikinski RL; Schreier LE
    Diabetes Nutr Metab; 2001 Feb; 14(1):27-36. PubMed ID: 11345163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paraoxonase gene polymorphism, serum lipid, and oxidized low-density lipoprotein in preeclampsia.
    Kim YJ; Park H; Lee HY; Ahn YM; Ha EH; Suh SH; Pang MG
    Eur J Obstet Gynecol Reprod Biol; 2007 Jul; 133(1):47-52. PubMed ID: 16949193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidation of remnant-like particles from serum of diabetic patients, patients with ischemic heart disease and normal subjects.
    Tamura M; Tanaka A; Yui K; Nakajima K; Numano F
    Horm Metab Res; 1997 Aug; 29(8):398-402. PubMed ID: 9288578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atherogenic lipoprotein particle size and concentrations and the effect of pravastatin in children with familial hypercholesterolemia.
    van der Graaf A; Rodenburg J; Vissers MN; Hutten BA; Wiegman A; Trip MD; Stroes ES; Wijburg FA; Otvos JD; Kastelein JJ
    J Pediatr; 2008 Jun; 152(6):873-8. PubMed ID: 18492534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of unique lipoprotein subclasses for visceral obesity by component analysis of cholesterol profile in high-performance liquid chromatography.
    Okazaki M; Usui S; Ishigami M; Sakai N; Nakamura T; Matsuzawa Y; Yamashita S
    Arterioscler Thromb Vasc Biol; 2005 Mar; 25(3):578-84. PubMed ID: 15637308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis and classification of proton NMR spectra of lipoprotein fractions from healthy volunteers and patients with cancer or CHD.
    Bathen TF; Engan T; Krane J; Axelson D
    Anticancer Res; 2000; 20(4):2393-408. PubMed ID: 10953302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of short- and long-term growth hormone replacement on lipoprotein composition and on very-low-density lipoprotein and low-density lipoprotein apolipoprotein B100 kinetics in growth hormone-deficient hypopituitary subjects.
    Kearney T; de Gallegos CN; Proudler A; Parker K; Anayaoku V; Bannister P; Venkatesan S; Johnston DG
    Metabolism; 2003 Jan; 52(1):50-9. PubMed ID: 12524662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.